Preclinical data show SENS-401 reduces loss of residual hearing after cochlear implantation Jan. 19, 2021
Phase I/II data shows therapeutic activity of OTO-413 across multiple speech-in-noise hearing tests Dec. 18, 2020
Astellas conducts phase I/II study of ASP-0598 for chronic tympanic membrane perforation July 28, 2020
RSS